By subhendu, 16 November, 2026 Unaudited Financial Results (Consolidated and Standalone) for Q2 FY 2027 Quarterly Results 2026-27 Q2 PDF Unaudited-Financial-Results_Q2FY27.pdf (659.98 KB)
By subhendu, 16 November, 2026 Newspaper Publication - Notice of Unclaimed Dividend & Shares to be transferred to IEPF for FY 2019-20 IEPF Details 2026-27 PDF Newspaper-Publication-IEPF_2019-20.pdf (9.75 MB)
By subhendu, 6 November, 2026 Neuland Laboratories Limited Q2 FY27 Earnings Call Transcript Transcripts 2026-27 Q2 PDF Neuland-Laboratories-Q2FY27-H1FY27-Earnings-Call-Transcript.pdf (247.66 KB)
By admin, 6 November, 2026 Schedule of Analyst / Institutional Investor Meeting – November 17, 2026 Analyst Meets 2026-27 Q2 PDF Analyst Meet_Nov 17 2026.pdf (278 KB)
By subhendu, 5 November, 2026 Change in Corporate Office Address of Registrar and Share Transfer Agent (RTA) Disclosures to Stock Exchange 2026-27 Q2 PDF SE-Intimation_Change-in-RTA-address.pdf (181.14 KB)
By subhendu, 4 November, 2026 Q2 FY 27 – Financial Results Newspaper Publication Board Meeting 2026-27 Q2 PDF SignedSEIntimationFRAdv-1.pdf (2.34 MB)
By admin, 3 November, 2026 Q2 – FY 27 Investor Call Recording Investor Call Recordings 2026-27 Q2 Audio NeulandLab-Earnings-Nov03-2026Audio.mp3 (32.45 MB)
By admin, 3 November, 2026 Neuland Press Release Q2 FY27 Disclosures to Stock Exchange 2026-27 Q2 PDF Q2FY27_Press_Release_Neuland_Lab_vF.pdf (384.18 KB)
By admin, 3 November, 2026 Neuland Investor Presentation Q2 FY27 Investor Presentations 2026-27 Q2 PDF Q2FY27_Investor_Presentation_Neuland Laboratories_vF.pdf (2.36 MB)
By admin, 3 November, 2026 Outcome of Board Meeting – 03/11/2026 Board Meeting 2026-27 Q2 PDF SEOutcome_03112026.pdf (659.98 KB)